| 10/17/23 |
Dean Mark Gladwin, MD, discusses the how artificial intelligence will revolutionize healthcare and what we need to do to prepare.
|
 |
| 09/15/23 |
A new study by UMSOM Dean Mark Gladwin, MD, and Anthony DeMartino, PhD (Medicine) on nitric oxide and its potential for therapeutic uses is featured in media and science publications.
|
 |
| 09/14/23 |
A new study by UMSOM Dean Mark Gladwin, MD, and Anthony DeMartino, PhD (Medicine) on nitric oxide and its potential for therapeutic uses is featured in media and science publications.
|
 |
| 09/14/23 |
A new study by UMSOM Dean Mark Gladwin, MD, and Anthony DeMartino, PhD (Medicine) on nitric oxide and its potential for therapeutic uses is featured in media and science publications.
|
 |
| 09/14/23 |
A new study by UMSOM Dean Mark Gladwin, MD, and Anthony DeMartino, PhD (Medicine) on nitric oxide and its potential for therapeutic uses is featured in media and science publications.
|
 |
| 06/15/23 |
UMSOM Dean Mark Gladwin and Dr. Sarah Kattakuzhy are quoted in this article about the new Kahlert Institute for Addiction Medicine.
|
 |
| 06/01/23 |
UMSOM's Dean Mark Gladwin, Dr. Eric Weintraub, and Dr. Sarah Kattakuzhy were quoted on press announcement of new Kahlert Institute for Addiction Medicine.
|
 |
| 05/31/23 |
UMSOM's Dean Mark Gladwin, Dr. Eric Weintraub, and Dr. Sarah Kattakuzhy were quoted on press announcement of new Kahlert Institute for Addiction Medicine. |
 |
| 05/31/23 |
UMSOM's Dean Mark Gladwin, Dr. Eric Weintraub, and Dr. Sarah Kattakuzhy were quoted on press announcement of new Kahlert Institute for Addiction Medicine. |
 |
| 05/31/23 |
UMSOM's Dean Mark Gladwin, Dr. Eric Weintraub, and Dr. Sarah Kattakuzhy were quoted on press announcement of new Kahlert Institute for Addiction Medicine. |
 |
| 05/31/23 |
UMSOM's Dean Mark Gladwin, Dr. Eric Weintraub, and Dr. Sarah Kattakuzhy were quoted on press announcement of new Kahlert Institute for Addiction Medicine. |
 |
| 02/01/23 |
UMSOM's Dr. Allan Doctor and Dean Mark Gladwin are quoted on new $46 million in federal funding to develop artificial blood product. |
 |
| 01/29/23 |
UMSOM Dean Mark Gladwin discusses the new University of Maryland-3 Institute for Health Computing and future plans. |
 |
| 01/28/23 |
UMSOM Dean Mark T. Gladwin discusses a new CVD-led study investigating an antimalarial monoclonal antibody. |
 |
| 01/27/23 |
UMSOM Dean Mark T. Gladwin comments on a new CVD-led challenge study of a monoclonal antibody for malaria. |
 |
| 01/10/23 |
UMSOM's Dean Gladwin announces hiring of new chief philanthropy officer Heather Culp. |
 |
| 01/10/23 |
UMSOM's Dean Gladwin announces hiring of new chief philanthropy officer Heather Culp. |
|
| 12/30/22 |
UMSOM's Dean Mark Gladwin provides information on the new Institute for Health Computing and efforts to spur investing in bio health innovation in Maryland.
|
 |
| 11/11/22 |
UMSOM's Dean Gladwin was quoted on the announcement of a new Institute of Health Computing that will be located in Montgomery County.
|
 |
| 11/10/22 |
UMSOM's Dean Gladwin discusses the new University of Maryland Institute of Health Computing.
|
 |
